Eptiday 0.75mg Injection

Composition Eptifibatide (0.75mg)
Rx Prescription Required
Pack vial of 100 ml Injection
Storage Store in a refrigerator (2 – 8°C). Do not freeze.
Chemical Class Amino acids, Peptides analogues
Action Class Glycoprotein IIb/IIIa Inhibitors
Habbit Forming
Manufacturer G C Chemie Pharmie Limited
Manufacturer address 5/C, Shree Laxmi Industrial Estate,, New Link Road,, Andheri West, Mumbai, Maharashtra 400053

Eptiday 0.75mg Injection is a blood thinner which prevents formation of harmful blood clots. It is used in the treatment of a heart attack and also prevents the clotting of blood in the heart during an angioplasty (procedure to improve blood flow to the heart).

Eptiday 0.75mg Injection is administered under the supervision of a doctor. Your doctor will decide the dose and duration of the medicine for you. You should continue all your other medicines that are advised by the doctor for your long-term treatment even after this injection.

Use of this medicine may cause low blood platelets and increase your risk of bleeding. Let your doctor know immediately if you see pinpoint rash or blood in your vomits, urine, or stool. It may also cause low blood pressure as a side effect. Your doctor will explain the benefits and risks associated with this medicine before it is administered.

This medicine is used with caution for some people. Before taking it, you must inform the doctor if you are suffering from any bleeding disorder, kidney or liver disease. Also, let your doctor know if you are pregnant or breastfeeding and about all the other medications that you are taking regularly.

Unstable angina

Prevention of Blood clots

Prevention of Heart attack

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Eptiday 0.75mg Injection is an antiplatelet medication. It works by preventing the platelets from sticking together, thereby decreasing the formation of harmful blood clots.

Q: What if you forget to take Eptiday Injection?
A: If you miss a dose of Eptiday 0.75mg Injection, please consult your doctor.

It is usually given by your nurse or doctor as an infusion (drip) into a vein.

It increases your risk of bleeding. Be careful while shaving, cutting fingernails or toenails or using sharp objects.

Notify your doctor if you see blood in your vomit, urine or stool (black, tarry stools or bright red blood).

Q. Can the use of Eptiday 0.75mg Injection increase the risk of bleeding?

Yes, Eptiday 0.75mg Injection increases the risk of bleeding. Always be careful while doing activities that may cause an injury or bleeding. Tell your doctor immediately if you notice any abnormal bruising or bleeding.

Q. What medicines should I avoid while taking Eptiday 0.75mg Injection?

Eptiday 0.75mg Injection can interact with several medicines. Do not take any medicine without talking to your doctor.

Q. When will I feel better after taking Eptiday 0.75mg Injection?

Eptiday 0.75mg Injection reduces your risk of developing blood clots in the blood vessels of your leg, lungs, heart and brain. You may not feel any difference after taking Eptiday 0.75mg Injection. However, keep taking this medicine as prescribed by your doctor because you will still be getting its full benefits.

In Prevention of Blood clots

Eptiday 0.75mg Injection prevents new blood clots from forming and prevents the existing ones from getting bigger. It works by blocking a substance in the body which is involved in blood clotting. Thus it helps your blood flow smoothly throughout the body. This can help reduce damage caused by clots in your lungs (pulmonary embolism), brain (stroke), heart (heart attack) or other blood vessels (thrombosis).

Bleeding

Decreased blood pressure

Alcohol:CONSULT YOUR DOCTOR

It is not known whether it is safe to consume alcohol with Eptiday 0.75mg Injection. Please consult your doctor.

Pregnancy:SAFE IF PRESCRIBED

Eptiday 0.75mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.

Breast feeding:CAUTION

Eptiday 0.75mg Injection should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.

Driving:NOT RELEVANT

Not relevant, as Eptiday 0.75mg Injection is intended for use in hospitalised patients.

Kidney:CAUTION

Eptiday 0.75mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Eptiday 0.75mg Injection may be needed. Please consult your doctor.Use of Eptiday 0.75mg Injection is not recommended in patients with severe kidney disease.

Liver:CONSULT YOUR DOCTOR

There is limited information available on the use of Eptiday 0.75mg Injection in patients with liver disease. Please consult your doctor.Use of Eptiday 0.75mg Injection is not recommended in patients with severe liver disease.

Weitz JI. Blood Coagulation and Anticoagulant, Fibrinolytic, and Antiplatelet Drugs. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 871.
Fox KA, White HD, Gersh BJ, et al. Antithrombotic Agents: Platelete Inhibitors, Acute Anticoagulants, Fibrinolytics, and Chronic Anticoagulants. In: Opie LH, Gersh BJ, editors. Drugs for the Heart. 8th ed. Philadelphia, Pennsylvania: Elsevier Saunders; 2013. pp. 355-56.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 485-46.
Eptifibatide. Ferentino, Italy: Patheon Italia S.p.A.; 1998 [revised Mar. 2013]. [Accessed 18 Mar. 2019] (online) Available from: View
Central Drugs Standard Control Organisation (CDSCO). Eptifibatide. [Accessed 18 Mar. 2019] (online) Available from: View